{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:22:06Z","timestamp":1791105726056,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T00:00:00Z","timestamp":1235520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gambl Stud"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s10899-009-9123-2","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T10:22:44Z","timestamp":1235470964000},"page":"425-431","source":"Crossref","is-referenced-by-count":68,"title":["Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia"],"prefix":"10.1007","volume":"25","author":[{"given":"Andrew J.","family":"Holman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"issue":"8","key":"9123_CR1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","volume":"68","author":"CB Aiken","year":"2007","unstructured":"Aiken, C. B. (2007). Pramipexole in psychiatry: A systemic review of the literature. The Journal of Clinical Psychiatry, 68(8), 1230\u20131236.","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"9123_CR2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","volume":"67","author":"SF Carville","year":"2008","unstructured":"Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., et al. (2008). EULAR evidenced based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases, 67(4), 536\u2013541. doi: 10.1136\/ard.2007.071522 .","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"9123_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10899-007-9060-x","volume":"23","author":"DS da Silva Lobo","year":"2007","unstructured":"da Silva Lobo, D. S., Vallada, H. P., Knight, J., et al. (2007). Dopamine genes and pathological gambling in discordant sib-pairs. Journal of Gambling Studies, 23(4), 421\u2013433. doi: 10.1007\/s10899-007-9060-x .","journal-title":"Journal of Gambling Studies"},{"key":"9123_CR4","first-page":"1","volume":"62","author":"ML Dodd","year":"2005","unstructured":"Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005). Pathological gambling caused by drugs used to treat Parkinson\u2019s disease. Archives of Neurology, 62, 1\u20135. doi: 10.1001\/archneur.62.9.noc50009 .","journal-title":"Archives of Neurology"},{"issue":"4","key":"9123_CR5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mds.21303","volume":"22","author":"AH Evans","year":"2007","unstructured":"Evans, A. H., & Butzkueven, H. (2007). Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Movement Disorders, 22(4), 590\u2013591. doi: 10.1002\/mds.21303 .","journal-title":"Movement Disorders"},{"issue":"12","key":"9123_CR6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","volume":"22","author":"DA Gallagher","year":"2007","unstructured":"Gallagher, D. A., O\u2019Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. (2007). Pathological gambling in Parkinson\u2019s disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Movement Disorders, 22(12), 1757\u20131763. doi: 10.1002\/mds.21611 .","journal-title":"Movement Disorders"},{"key":"9123_CR7","volume-title":"Impulse control disorders: A clinician\u2019s guide to understanding and treating behavioral addictions","author":"JE Grant","year":"2008","unstructured":"Grant, J. E. (2008). Impulse control disorders: A clinician\u2019s guide to understanding and treating behavioral addictions. New York: WW Norton."},{"issue":"12","key":"9123_CR8","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/mds.21110","volume":"21","author":"KA Grosset","year":"2006","unstructured":"Grosset, K. A., Macphee, G., Pal, G., et al. (2006). Problematic gambling on dopamine agonists: Not such a rarity. Movement Disorders, 21(12), 2206\u20132208. doi: 10.1002\/mds.21110 .","journal-title":"Movement Disorders"},{"issue":"4","key":"9123_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.rhu.0000081264.26484.e5","volume":"9","author":"AJ Holman","year":"2003","unstructured":"Holman, A. J. (2003a). Ropinirole, a dopamine agonist, for refractory fibromyalgia: Preliminary observations. Journal of Clinical Rheumatology; Practical Reports on Rheumatic & Musculoskeletal Diseases, 9(4), 277\u2013279. doi: 10.1097\/01.rhu.0000081264.26484.e5 .","journal-title":"Journal of Clinical Rheumatology; Practical Reports on Rheumatic & Musculoskeletal Diseases"},{"issue":"12","key":"9123_CR10","first-page":"2733","volume":"30","author":"AJ Holman","year":"2003","unstructured":"Holman, A. J. (2003b). Pramipexole and fibromyalgia: Promise and precaution. Journal of Rheumatology, 30(12), 2733. letter.","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"9123_CR11","first-page":"S698","volume":"50","author":"AJ Holman","year":"2004","unstructured":"Holman, A. J. (2004). Treatment of fibromyalgia with the dopamine agonist ropinirole a 14-week double-blind, pilot, randomized controlled trial with 14-week blinded extension. Arthritis and Rheumatism, 50(9), S698. abstract.","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"9123_CR12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.21191","volume":"52","author":"AJ Holman","year":"2005","unstructured":"Holman, A. J., & Myers, R. R. (2005). A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis and Rheumatism, 52(8), 2495\u20132505. doi: 10.1002\/art.21191 .","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"9123_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1300\/J094v12n01_10","volume":"12","author":"AJ Holman","year":"2004","unstructured":"Holman, A. J., Neiman, R. A., & Ettlinger, R. E. (2004). Preliminary efficacy of the dopamine against, pramipexole for fibromyalgia: The first, open label, multicenter experience. Journal of Musculoskeletal Pain, 12(1), 69\u201374. doi: 10.1300\/J094v12n01_10 .","journal-title":"Journal of Musculoskeletal Pain"},{"issue":"1","key":"9123_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S., Stern, M. B., et al. (2008). Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Movement Disorders, 23(1), 75\u201380. doi: 10.1002\/mds.21770 .","journal-title":"Movement Disorders"},{"issue":"1\u20133","key":"9123_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2006.12.005","volume":"102","author":"RS McIntyre","year":"2007","unstructured":"McIntyre, R. S., McElroy, S. L., Konarski, J. Z., Soczynska, J. K., Wilkins, K., & Kennedy, S. H. (2007). Problem gambling in bipolar disorder: Results of the Canadian Community Health Survey. Journal of Affective Disorders, 102(1\u20133), 27\u201334. doi: 10.1016\/j.jad.2006.12.005 .","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"9123_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","volume":"14","author":"WG Ondo","year":"2008","unstructured":"Ondo, W. G., & Lai, D. (2008). Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism & Related Disorders, 14(1), 28\u201332. doi: 10.1016\/j.parkreldis.2007.05.006 .","journal-title":"Parkinsonism & Related Disorders"},{"issue":"8","key":"9123_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2006.10.001","volume":"13","author":"J Quickfall","year":"2007","unstructured":"Quickfall, J., & Suchowersky, O. (2007). Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism & Related Disorders, 13(8), 535\u2013536. doi: 10.1016\/j.parkreldis.2006.10.001 .","journal-title":"Parkinsonism & Related Disorders"},{"issue":"12","key":"9123_CR18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2007.01.009","volume":"14","author":"A Singh","year":"2007","unstructured":"Singh, A., Kandimala, G., Dewey, R. B., Jr, & O\u2019Suilleabhain, P. (2007). Risk factors for pathological gambling and other compulsions among Parkinson\u2019s disease patients taking dopamine agonists. Journal of Clinical Neuroscience, 14(12), 1178\u20131181. doi: 10.1016\/j.jocn.2007.01.009 .","journal-title":"Journal of Clinical Neuroscience"},{"key":"9123_CR19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.mehy.2003.10.013","volume":"62","author":"PB Wood","year":"2004","unstructured":"Wood, P. B. (2004). Stress and dopamine: Implications for the pathophysiology of chronic widespread pain. Medical Hypotheses, 62, 420\u2013424. doi: 10.1016\/j.mehy.2003.10.013 .","journal-title":"Medical Hypotheses"},{"key":"9123_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pain.2005.12.014","volume":"120","author":"PB Wood","year":"2006","unstructured":"Wood, P. B. (2006). Mesolimbic dopaminergic mechanisms and pain control. Pain, 120, 230\u2013234. doi: 10.1016\/j.pain.2005.12.014 .","journal-title":"Pain"},{"issue":"1","key":"9123_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpain.2006.05.014","volume":"8","author":"PB Wood","year":"2007","unstructured":"Wood, P. B., Patterson, J. C., Sunderland, J. J., Tainter, J. H., Glabus, M. F., & Lilien, D. L. (2007). Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. Pain, 8(1), 51\u201358. doi: 10.1016\/j.jpain.2006.05.014 .","journal-title":"Pain"}],"container-title":["Journal of Gambling Studies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10899-009-9123-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10899-009-9123-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10899-009-9123-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:10:04Z","timestamp":1559265004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10899-009-9123-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9123"],"URL":"https:\/\/doi.org\/10.1007\/s10899-009-9123-2","relation":{},"ISSN":["1050-5350","1573-3602"],"issn-type":[{"value":"1050-5350","type":"print"},{"value":"1573-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,25]]}}}